Edesa Biotech is trading 6.72% up at $5.08, versus the September 3, 2026 close of $4.76, with no clear company-specific announcement dated September 4 identified.
- Latest listed releases are its August 19 public offering and August 13 fiscal third-quarter results.
- The broader market is mixed ahead of U.S. employment data.
- The move remains an unexplained, low-volume-style reaction rather than a confirmed catalyst.